YTHDC2 and nasopharyngeal carcinoma: YTHDC2 can bind to insulin-like growth factor 1 receptor (IGF1R) mRNA and activate IGF1R-AKT/S6 signaling, promoting radio-resistance of NPC cells (See Table 2).